2016
DOI: 10.1371/journal.pntd.0005103
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Musculoskeletal Disabilities following Snake Envenoming in Sri Lanka: A Population-Based Study

Abstract: BackgroundSnakebite is a major public health problem in agricultural communities in the tropics leading to acute local and systemic impairments with resultant disabilities. Snakebite related long-term musculoskeletal disabilities have been a neglected area of research. We conducted a population-based, cross-sectional study in an agricultural community to describe the chronic musculoskeletal disabilities of snake envenoming.Methodology/Principal FindingsA sample representative of residents of a single district … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
27
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 36 publications
(29 citation statements)
references
References 15 publications
1
27
0
Order By: Relevance
“…The detailed descriptions of these musculoskeletal complications of snakebite have been recently published. 13 A need for therapies to counteract local venom effects has been recognized and used against some species. 14 …”
Section: Discussionmentioning
confidence: 99%
“…The detailed descriptions of these musculoskeletal complications of snakebite have been recently published. 13 A need for therapies to counteract local venom effects has been recognized and used against some species. 14 …”
Section: Discussionmentioning
confidence: 99%
“…Although sufficient in most cases, snakebite treatments have been challenged by the continuous high numbers of clinical illness and mortality associated with snakebites worldwide (WHO, 2018). Furthermore, chronic morbidity following snakebites have been underestimated, with many victims reporting chronic symptoms in the bitten region, including complex regional pain syndrome (CRPA) (Seo et al, 2014;Kleggetveit et al, 2016) and musculoskeletal disabilities (Jayawardana et al, 2016). Available snakebite treatments face challenges associated with limited para-specificity, poor antibody specificity, high incidences of adverse reactions, low availability and poor affordability to those who need them, along with poor efficacy against local tissue effects (Williams et al, 2011;Gutierrez et al, 2017;Ainsworth et al, 2018;Harrison et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“…In most cases, acute symptoms induced by snakebite envenomation can be relieved within days after antivenom injection. However, sequelae or delayed pathological effects could last for months or years [11,[25][26][27][28][29].…”
Section: Introductionmentioning
confidence: 99%